FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
This Quarter Return
+1.45%
1 Year Return
+33.53%
3 Year Return
+83.32%
5 Year Return
+196.78%
10 Year Return
+650.37%
AUM
$179M
AUM Growth
+$179M
(-4.1%)
Cap. Flow
-$6.02M
Cap. Flow
% of AUM
-3.36%
Top 10 Holdings %
Top 10 Hldgs %
36.27%
Holding
157
New
8
Increased
25
Reduced
68
Closed
12
Top Buys
| 1 |
Pfizer
PFE
|
$1.36M |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
$752K |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$743K |
| 4 |
iShares Short Treasury Bond ETF
SHV
|
$694K |
| 5 |
Invesco Senior Loan ETF
BKLN
|
$525K |
Top Sells
| 1 |
Apple
AAPL
|
$1.22M |
| 2 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
$669K |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$584K |
| 4 |
Ubiquiti
UI
|
$475K |
| 5 |
Caterpillar
CAT
|
$398K |
Sector Composition
| 1 | Healthcare | 33.01% |
| 2 | Energy | 7.37% |
| 3 | Consumer Staples | 6.07% |
| 4 | Financials | 5.67% |
| 5 | Consumer Discretionary | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $17.2M | 9.58% | 355,509 -3,585 | -1% | -$173K |
|
|
MYOK
2
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $13.6M | 7.61% | 279,673 +15,219 | +6% | +$743K |
|
|
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $7.48M | 4.17% | 228,873 +296 | +0.1% | +$9.67K |
|
4
iShares Core S&P 500 ETF
IVV
$662B
| $5.42M | 3.02% | 20,411 -1,259 | -6% | -$334K |
|
5
Altria Group
MO
$113B
| $4.42M | 2.47% | 70,994 +1,050 | +2% | +$65.4K |
|
6
Meta Platforms (Facebook)
META
$1.86T
| $3.81M | 2.13% | 23,852 -361 | -1% | -$57.7K |
|
7
Gilead Sciences
GILD
$140B
| $3.52M | 1.96% | 46,643 -2,600 | -5% | -$196K |
|
8
iShares US Consumer Staples ETF
IYK
$1.35B
| $3.4M | 1.9% | 28,595 -995 | -3% | -$118K |
|
9
iShares Select Dividend ETF
DVY
$20.8B
| $3.26M | 1.82% | 34,309 +3,349 | +11% | +$319K |
|
10
CVS Health
CVS
$92.8B
| $2.89M | 1.61% | 46,373 -500 | -1% | -$31.1K |
|
11
iShares Russell 2000 ETF
IWM
$67B
| $2.86M | 1.59% | 18,814 -477 | -2% | -$72.4K |
|
12
Philip Morris
PM
$260B
| $2.73M | 1.52% | 27,416 -667 | -2% | -$66.3K |
|
13
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $2.57M | 1.43% | 13,708 +73 | +0.5% | +$13.7K |
|
14
Biogen
BIIB
$19.4B
| $2.51M | 1.4% | 9,175 -500 | -5% | -$137K |
|
15
Visa
V
$683B
| $2.46M | 1.37% | 20,567 -2,695 | -12% | -$322K |
|
16
Union Pacific
UNP
$133B
| $2.43M | 1.35% | 18,060 | – | – |
|
17
iShares Russell 1000 ETF
IWB
$43.2B
| $2.4M | 1.34% | 16,344 -185 | -1% | -$27.2K |
|
18
Johnson & Johnson
JNJ
$427B
| $2.35M | 1.31% | 18,348 -1,275 | -6% | -$163K |
|
19
Iron Mountain
IRM
$27.3B
| $2.22M | 1.24% | 67,604 -5,104 | -7% | -$168K |
|
20
Golar LNG
GLNG
$4.48B
| $2.2M | 1.23% | 80,250 | – | – |
|
21
Agios Pharmaceuticals
AGIO
$2.19B
| $2.06M | 1.15% | 25,150 -2,400 | -9% | -$196K |
|
|
IMGN
22
DELISTED
Immunogen Inc
IMGN
| $2.04M | 1.14% | 193,500 -31,000 | -14% | -$326K |
|
23
iShares MSCI EAFE ETF
EFA
$66B
| $1.93M | 1.08% | 27,683 -657 | -2% | -$45.8K |
|
24
Phillips 66
PSX
$54B
| $1.91M | 1.07% | 19,951 -100 | -0.5% | -$9.59K |
|
25
Vanguard Mega Cap Growth ETF
MGK
$28.9B
| $1.91M | 1.07% | 17,022 -1,698 | -9% | -$191K |
|